Literature DB >> 28433673

Montreal Accord on Patient-Reported Outcomes (PROs) use series - Paper 2: terminology proposed to measure what matters in health.

Nancy E Mayo1, Sabrina Figueiredo2, Sara Ahmed3, Susan J Bartlett4.   

Abstract

BACKGROUND: We outline different health outcomes and describe how multiple perspectives can be harnessed to optimize accuracy of key data collected about patients with chronic conditions. The terms health status, health-related quality of life, and quality of life are often used interchangeably without recognizing that they have different meanings, as are the terms used to refer to the different components of function. Although the advantages and limitations of existing frameworks and perspectives are largely understood, greater precision is needed when using health outcome terminology and identifying optimal sources of information.
OBJECTIVE: A refinement of the current taxonomy is proposed to distinguish between patient-reported outcomes and self-report outcomes and expand the concept of clinically reported outcomes to include those assessed by performance and emerging technologies. DISCUSSION: Health outcomes yield important information that can be used to improve the lives of many people. Now is the time to "talk the talk" as part of larger coordinated efforts within and across countries to identify and measure what matters most in health.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Health; Health status; Health-related quality of life; Measurement; Outcomes; Quality of life

Mesh:

Year:  2017        PMID: 28433673     DOI: 10.1016/j.jclinepi.2017.04.013

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  7 in total

1.  Using Consumer-Wearable Activity Trackers for Risk Prediction of Life-Threatening Heart Arrhythmia in Patients with an Implantable Cardioverter-Defibrillator: An Exploratory Observational Study.

Authors:  Diana My Frodi; Vlad Manea; Søren Zöga Diederichsen; Jesper Hastrup Svendsen; Katarzyna Wac; Tariq Osman Andersen
Journal:  J Pers Med       Date:  2022-06-08

2.  Co-Calibrating Physical and Psychological Outcomes and Consumer Wearable Activity Outcomes in Older Adults: An Evaluation of the coQoL Method.

Authors:  Vlad Manea; Katarzyna Wac
Journal:  J Pers Med       Date:  2020-10-31

Review 3.  The use of proxies and proxy-reported measures: a report of the international society for quality of life research (ISOQOL) proxy task force.

Authors:  Jessica K Roydhouse; Matthew L Cohen; Henrik R Eshoj; Nadia Corsini; Emre Yucel; Claudia Rutherford; Katarzyna Wac; Allan Berrocal; Alyssa Lanzi; Cindy Nowinski; Natasha Roberts; Angelos P Kassianos; Veronique Sebille; Madeleine T King; Rebecca Mercieca-Bebber
Journal:  Qual Life Res       Date:  2021-07-12       Impact factor: 4.147

4.  Baduanjin Qigong Intervention by Telerehabilitation (TeleParkinson): A Proof-of-Concept Study in Parkinson's Disease.

Authors:  Livia P Carvalho; Simon Décary; Isabelle Beaulieu-Boire; Rosalie Dostie; Isabelle Lalonde; Émilie Texier; Laurence Laprise; Elizabeth Pepin; Mélodie Gilbert; Hélène Corriveau; Michel Tousignant
Journal:  Int J Environ Res Public Health       Date:  2021-06-30       Impact factor: 3.390

5.  Complementing Human Behavior Assessment by Leveraging Personal Ubiquitous Devices and Social Links: An Evaluation of the Peer-Ceived Momentary Assessment Method.

Authors:  Katarzyna Wac; Allan Berrocal; Waldo Concepcion; Stefano De Dominicis
Journal:  JMIR Mhealth Uhealth       Date:  2020-08-07       Impact factor: 4.773

6.  Are the Items of the Starkstein Apathy Scale Fit for the Purpose of Measuring Apathy Post-stroke?

Authors:  Stanley Hum; Lesley K Fellows; Christiane Lourenco; Nancy E Mayo
Journal:  Front Psychol       Date:  2021-12-07

Review 7.  Quality of mobility measures among individuals with acquired brain injury: an umbrella review.

Authors:  Rehab Alhasani; Claudine Auger; Matheus Paiva Azevedo; Sara Ahmed
Journal:  Qual Life Res       Date:  2022-03-11       Impact factor: 3.440

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.